Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis

Abstract The pathogenesis of SARS-CoV-2 remains to be completely understood, and detailed SARS-CoV-2 cellular cytopathic effects requires definition. We performed a comparative ultrastructural study of SARS-CoV-1 and SARS-CoV-2 infection in Vero E6 cells and in lungs from deceased COVID-19 patients....

Full description

Bibliographic Details
Main Authors: Roberta Nardacci, Francesca Colavita, Concetta Castilletti, Daniele Lapa, Giulia Matusali, Silvia Meschi, Franca Del Nonno, Daniele Colombo, Maria Rosaria Capobianchi, Alimuddin Zumla, Giuseppe Ippolito, Mauro Piacentini, Laura Falasca
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-021-03527-9
id doaj-49896830da8e46058a1f5adee38c5f04
record_format Article
spelling doaj-49896830da8e46058a1f5adee38c5f042021-03-14T12:03:10ZengNature Publishing GroupCell Death and Disease2041-48892021-03-0112311210.1038/s41419-021-03527-9Evidences for lipid involvement in SARS-CoV-2 cytopathogenesisRoberta Nardacci0Francesca Colavita1Concetta Castilletti2Daniele Lapa3Giulia Matusali4Silvia Meschi5Franca Del Nonno6Daniele Colombo7Maria Rosaria Capobianchi8Alimuddin Zumla9Giuseppe Ippolito10Mauro Piacentini11Laura Falasca12Laboratory of Electron Microscopy, National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCSLaboratory of Virology, National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCSLaboratory of Virology, National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCSLaboratory of Virology, National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCSLaboratory of Virology, National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCSLaboratory of Virology, National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCSPathology Unit, National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCSPathology Unit, National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCSLaboratory of Virology, National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCSDepartment of Infection, Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation TrustScientific Direction; National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCSLaboratory of Electron Microscopy, National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCSLaboratory of Electron Microscopy, National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCSAbstract The pathogenesis of SARS-CoV-2 remains to be completely understood, and detailed SARS-CoV-2 cellular cytopathic effects requires definition. We performed a comparative ultrastructural study of SARS-CoV-1 and SARS-CoV-2 infection in Vero E6 cells and in lungs from deceased COVID-19 patients. SARS-CoV-2 induces rapid death associated with profound ultrastructural changes in Vero cells. Type II pneumocytes in lung tissue showed prominent altered features with numerous vacuoles and swollen mitochondria with presence of abundant lipid droplets. The accumulation of lipids was the most striking finding we observed in SARS-CoV-2 infected cells, both in vitro and in the lungs of patients, suggesting that lipids can be involved in SARS-CoV-2 pathogenesis. Considering that in most cases, COVID-19 patients show alteration of blood cholesterol and lipoprotein homeostasis, our findings highlight a peculiar important topic that can suggest new approaches for pharmacological treatment to contrast the pathogenicity of SARS-CoV-2.https://doi.org/10.1038/s41419-021-03527-9
collection DOAJ
language English
format Article
sources DOAJ
author Roberta Nardacci
Francesca Colavita
Concetta Castilletti
Daniele Lapa
Giulia Matusali
Silvia Meschi
Franca Del Nonno
Daniele Colombo
Maria Rosaria Capobianchi
Alimuddin Zumla
Giuseppe Ippolito
Mauro Piacentini
Laura Falasca
spellingShingle Roberta Nardacci
Francesca Colavita
Concetta Castilletti
Daniele Lapa
Giulia Matusali
Silvia Meschi
Franca Del Nonno
Daniele Colombo
Maria Rosaria Capobianchi
Alimuddin Zumla
Giuseppe Ippolito
Mauro Piacentini
Laura Falasca
Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis
Cell Death and Disease
author_facet Roberta Nardacci
Francesca Colavita
Concetta Castilletti
Daniele Lapa
Giulia Matusali
Silvia Meschi
Franca Del Nonno
Daniele Colombo
Maria Rosaria Capobianchi
Alimuddin Zumla
Giuseppe Ippolito
Mauro Piacentini
Laura Falasca
author_sort Roberta Nardacci
title Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis
title_short Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis
title_full Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis
title_fullStr Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis
title_full_unstemmed Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis
title_sort evidences for lipid involvement in sars-cov-2 cytopathogenesis
publisher Nature Publishing Group
series Cell Death and Disease
issn 2041-4889
publishDate 2021-03-01
description Abstract The pathogenesis of SARS-CoV-2 remains to be completely understood, and detailed SARS-CoV-2 cellular cytopathic effects requires definition. We performed a comparative ultrastructural study of SARS-CoV-1 and SARS-CoV-2 infection in Vero E6 cells and in lungs from deceased COVID-19 patients. SARS-CoV-2 induces rapid death associated with profound ultrastructural changes in Vero cells. Type II pneumocytes in lung tissue showed prominent altered features with numerous vacuoles and swollen mitochondria with presence of abundant lipid droplets. The accumulation of lipids was the most striking finding we observed in SARS-CoV-2 infected cells, both in vitro and in the lungs of patients, suggesting that lipids can be involved in SARS-CoV-2 pathogenesis. Considering that in most cases, COVID-19 patients show alteration of blood cholesterol and lipoprotein homeostasis, our findings highlight a peculiar important topic that can suggest new approaches for pharmacological treatment to contrast the pathogenicity of SARS-CoV-2.
url https://doi.org/10.1038/s41419-021-03527-9
work_keys_str_mv AT robertanardacci evidencesforlipidinvolvementinsarscov2cytopathogenesis
AT francescacolavita evidencesforlipidinvolvementinsarscov2cytopathogenesis
AT concettacastilletti evidencesforlipidinvolvementinsarscov2cytopathogenesis
AT danielelapa evidencesforlipidinvolvementinsarscov2cytopathogenesis
AT giuliamatusali evidencesforlipidinvolvementinsarscov2cytopathogenesis
AT silviameschi evidencesforlipidinvolvementinsarscov2cytopathogenesis
AT francadelnonno evidencesforlipidinvolvementinsarscov2cytopathogenesis
AT danielecolombo evidencesforlipidinvolvementinsarscov2cytopathogenesis
AT mariarosariacapobianchi evidencesforlipidinvolvementinsarscov2cytopathogenesis
AT alimuddinzumla evidencesforlipidinvolvementinsarscov2cytopathogenesis
AT giuseppeippolito evidencesforlipidinvolvementinsarscov2cytopathogenesis
AT mauropiacentini evidencesforlipidinvolvementinsarscov2cytopathogenesis
AT laurafalasca evidencesforlipidinvolvementinsarscov2cytopathogenesis
_version_ 1724221539490988032